by Vivian Frankel | Jun 22, 2021 | Article, Compounding Pharmacy, Headline
Meeting Tougher PPE Standards a Manageable Task By Gina Shaw – Pharmacy Practice News Matt Kelm, PharmD, MHA Complying with new, more stringent requirements for personal protective equipment (PPE) under USP Chapter <800> can be done without unduly...
by Vivian Frankel | Feb 5, 2021 | Compounding Pharmacy, Headline
FDA approved a new drug application (NDA) for Veklury (remdesivir), a drug indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization on October 22, 2020. The Veklury...
by Vivian Frankel | Feb 4, 2021 | Compounding Pharmacy, Headline
The Institute for Safe Medication Practices on Jan. 27 released its list of the top 10 medication errors from 2020, selecting errors and hazards that have not only been consistently reported, but also can be avoided or minimized through operational improvements. The...
by Vivian Frankel | Jan 26, 2021 | Compounding Pharmacy, Headline
New standards for drug compounding in USP Chapter <800> include more stringent requirements for personal protective equipment (PPE). How will these new requirements impact pharmacy workflow? A new study from Duke University Hospital, presented at the ASHP 2020...
by Vivian Frankel | Jan 21, 2021 | Compounding Pharmacy, Headline
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Jan 19, 2021– MEDISCA, a global leader in the pharmaceutical compounding industry, is proud to announce a partnership with Ananda Health, the leading CBD provider to US independent pharmacies. MEDISCA will be the...
by Vivian Frankel | Jan 7, 2021 | Headline
With the COVID-19 immunization campaign moving much more slowly than anticipated, vaccine makers and federal officials are under pressure to do more with the supply on hand. Potential solutions include potentially cutting doses of the Moderna vaccine in half and using...